Stories
Slash Boxes
Comments

SoylentNews is people

posted by martyb on Tuesday August 23 2016, @07:34AM   Printer-friendly
from the staying-alive-is-getting-more-expensive dept.

EpiPen's price has ballooned about 400% since 2008, rising from about a $100 list price to $500 today. The EpiPen is one of the most important life-saving medical innovations for people with severe food allergies—which affect as many as 15 million Americans and 1 in 13 children in the United States. But its price has exploded over the last decade despite few upgrades to the product itself. The product's lack of competitors is likely a significant driver of the costs. [...] [The] EpiPen enjoys a near-monopoly on the market with annual sales of more than $1.3 billion and nearly 90% U.S. market share.

At Fortune, NYT, The Hill.


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 0) by Anonymous Coward on Tuesday August 23 2016, @04:09PM

    by Anonymous Coward on Tuesday August 23 2016, @04:09PM (#392193)

    That would not be enough to even cover the costs of a Phase I clinical trial. It would maybe be enough for the pre-clinical work.